Targeted therapy for malignant glioma patients: Lessons learned and the road ahead-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted therapy for malignant glioma patients: Lessons learned and the road ahead

Published:2009-07 Issue:3 Volume:6 Page:500-512
ISSN:1933-7213
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Huang Tiffany T.,Sarkaria Shawn M.,Cloughesy Timothy F.,Mischel Paul S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Clinical Neurology,Pharmacology

Link

http://www.springerlink.com/index/pdf/10.1016/j.nurt.2009.04.008

Reference125 articles.

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100: 57–70.

2. Bishop JM. Molecular themes in oncogenesis. Cell 1991;64: 235–248.

3. Bruna A, Darken RS, Rojo F, et al. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 2007;11: 147–160.

4. Yoshida D, Kim K, Noha M, Teramoto A. Hypoxia inducible factor 1-alpha regulates of platelet derived growth factor-B in human glioblastoma cells. J Neurooncol 2006;76: 13–21.

5. Arrieta O, Garcia E, Guevara P, et al. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. Cancer 2002;94: 3210–3218.

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Origin recognition complex 6 overexpression promotes growth of glioma cells;Cell Death & Disease;2024-07-06

2. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

3. Recent advances in understanding brain cancer metabolomics: a review;Medical Oncology;2023-07-04

4. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies;International Journal of Molecular Sciences;2023-06-21

5. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth;International Journal of Biological Sciences;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3